Efficacy of ursodeoxycholic acid in reducing the necessity of cholecystectomy due to pre-existing and subsequently formed gallstones in patients who underwent laparoscopic sleeve gastrectomy

dc.contributor.authorDemirpolat, Muhammed Taha
dc.contributor.authorÇelikkaya, Muhammet Oğuz
dc.contributor.authorErtekin, Süleyman Çağlar
dc.contributor.authorBaşak, Fatih
dc.contributor.authorŞişik, Abdullah
dc.date.accessioned2025-01-29T10:32:27Z
dc.date.available2025-01-29T10:32:27Z
dc.date.issued2024en_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü,Genel Cerrahi Ana Bilim Dalıen_US
dc.description.abstractBackground: In this study, we aimed to investigate whether ursodeoxycholic acid (UDCA) would reduce the necessity of cholecystectomy in patients diagnosed with asymptomatic gallstones after laparoscopic sleeve gastrectomy (LSG) and in patients diagnosed with asymptomatic gallstones before LSG. Methods: Between July 2020 and November 2022, at least 2-year follow-ups of patients who underwent LSG for obesity were retrospectively analyzed. Patients with pre-existing asymptomatic gallstones during preoperative evaluation, those with UDCA treatment (group 1), and observation group (group 2). Patients with newly formed gallstones in postoperative outpatient clinic follow-up, those with UDCA treatment (group A), and those without UDCA treatment (group B). Results: A total of 425 patients included. At the end of the first year, patients who had newly formed gallstones after LSG had a higher total weight loss percentages (TWL%) (39.8 ± 6.1) compared to those who did not develop gallstones (37.9 ± 7.4), which were statistically significant (p = 0.004). Among patients who developed gallstones postoperatively, UDCA treatment was associated with a significantly lower cholecystectomy rate in patients with newly formed gallstones postoperatively (p = 0.025), while no significant difference was shown in patients with preoperative gallstones (p = 0.631). Conclusion: UDCA is a promising option for reducing the need for cholecystectomy in patients with post-LSG gallstones, but it appears ineffective for pre-existing gallstones.en_US
dc.identifier.citationDemirpolat, M. T., Çelikkaya, M. O., Ertekin, S. Ç., Başak, F., Şişik, A. (2025). Efficacy of ursodeoxycholic acid in reducing the necessity of cholecystectomy due to pre-existing and subsequently formed gallstones in patients who underwent laparoscopic sleeve gastrectomy. BMC Surgery, 25(1). 10.1186/s12893-025-02767-2en_US
dc.identifier.issn1471-2482
dc.identifier.issue1en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12939/5154
dc.identifier.volume25en_US
dc.identifier.wosWOS:001401080500002
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.relation.ispartofBMC Surgery
dc.relation.isversionof10.1186/s12893-025-02767-2en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGallstonesen_US
dc.subjectLaparoscopic sleeve gastrectomyen_US
dc.subjectThe necessity of cholecystectomyen_US
dc.subjectUrsodeoxycholic aciden_US
dc.titleEfficacy of ursodeoxycholic acid in reducing the necessity of cholecystectomy due to pre-existing and subsequently formed gallstones in patients who underwent laparoscopic sleeve gastrectomy
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
s12893-025-02767-2.pdf
Boyut:
1.28 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: